These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12614873)

  • 1. Structure-activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists.
    Naya A; Ishikawa M; Matsuda K; Ohwaki K; Saeki T; Noguchi K; Ohtake N
    Bioorg Med Chem; 2003 Mar; 11(6):875-84. PubMed ID: 12614873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and discovery of a novel CCR1 antagonist.
    Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
    J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist.
    Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
    Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):697-701. PubMed ID: 12808249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel CCR3 selective antagonist.
    Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
    Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization and antimicrobial activity of novel xanthene sulfonamide and carboxamide derivatives.
    Kaya M; Demir E; Bekci H
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):885-93. PubMed ID: 22803669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist.
    de Mendonça FL; da Fonseca PC; Phillips RM; Saldanha JW; Williams TJ; Pease JE
    J Biol Chem; 2005 Feb; 280(6):4808-16. PubMed ID: 15548526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small-molecule antagonist of human and murine CCR1 receptors.
    Fernandez-Botran R
    Expert Opin Investig Drugs; 2001 Jul; 10(7):1387-9. PubMed ID: 11791502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperazinyl CCR1 antagonists--optimization of human liver microsome stability.
    Brown MF; Bahnck KB; Blumberg LC; Brissette WH; Burrell SA; Driscoll JP; Fedeles F; Fisher MB; Foti RS; Gladue RP; Guzman-Martinez A; Hayward MM; Lira PD; Lillie BM; Lu Y; Lundquist GD; McElroy EB; McGlynn MA; Paradis TJ; Poss CS; Roache JH; Shavnya A; Shepard RM; Trevena KA; Tylaska LA
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3109-12. PubMed ID: 17383873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
    J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives.
    Imamura S; Ishihara Y; Hattori T; Kurasawa O; Matsushita Y; Sugihara Y; Kanzaki N; Iizawa Y; Baba M; Hashiguchi S
    Chem Pharm Bull (Tokyo); 2004 Jan; 52(1):63-73. PubMed ID: 14709870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 2-aminothiazole-4-carboxamides, a novel class of muscarinic M(3) selective antagonists, through solution-phase parallel synthesis.
    Sagara Y; Mitsuya M; Uchiyama M; Ogino Y; Kimura T; Ohtake N; Mase T
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):437-40. PubMed ID: 15802848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1).
    Berkhout TA; Gohil J; Gonzalez P; Nicols CL; Moores KE; Macphee CH; White JR; Groot PH
    Biochem Pharmacol; 2000 Mar; 59(5):591-6. PubMed ID: 10660125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
    Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
    J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists.
    Xin Z; Zhao H; Serby MD; Liu B; Schaefer VG; Falls DH; Kaszubska W; Colins CA; Sham HL; Liu G
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1201-4. PubMed ID: 15686942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.
    Allen DR; Bolt A; Chapman GA; Knight RL; Meissner JW; Owen DA; Watson RJ
    Bioorg Med Chem Lett; 2007 Feb; 17(3):697-701. PubMed ID: 17097877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
    Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
    J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
    Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor.
    Liang M; Rosser M; Ng HP; May K; Bauman JG; Islam I; Ghannam A; Kretschmer PJ; Pu H; Dunning L; Snider RM; Morrissey MM; Hesselgesser J; Perez HD; Horuk R
    Eur J Pharmacol; 2000 Feb; 389(1):41-9. PubMed ID: 10686294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
    Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.